Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment

A method of relieving a human patient of pain, discomfort and tissue inflammation associated with arthritis, bursitis, fibromyalgia, carpal tunnel syndrome, or gout, comprising the step of

• topically applying to the skin of the patient a liquid cannabinoid liniment composition consisting of from about 97.5% to about 99.5% by weight of 70% isopropyl alcohol solution;
• and
• from about 0.5% to about 2.5% by weight of a cannabinoid mixture extracted from the female plant Cannabis sativa L, in said isopropyl alcohol solution including in combination:
• 9-Tetrahydrocannabinol (delta-9-THC), 9-THC Propyl Analogue (THC-V), Cannabidiol (CBD), Cannabidiol Propyl Analogue (CBD-V), Cannabinol (CBN), Cannabichromene (CBC), Cannabichromene Propyl Analogue (CBC-V), Cannabigerol (CBG), cannabinoid terpenoids, and cannabinoid flavonoids;
• wherein
• the constituents of said mixture are absorbed through the skin and interact with cannabinoid receptors in the body and tissues of the patient to produce therapeutic analgesic and anti-inflammatory effects without producing undesirable psychotropic side effects;
• said Tetrehydrocannabinol (delta-9-THC) providing analgesic and anti-inflammatory effects, said Cannabidiol (CBD) providing potent antioxidant, neuroprotective and anti-inflammatory effects and reducing psychoactive effects of said Tetrahydrocannabinol (delta-9-THC), said Cannabichromene (CBC) providing sedative and analgesic effects, said Cannabigerol (CBG) providing sedative and anti-microbial effects, and said cannaboinoid terpenoids and cannabinoid flavonoids providing anti-inflammatory effects.